FI873553A - Vid behandling och diagnosticering av hiv-infektioner anvaendbara monoklonala antikroppar och peptider. - Google Patents

Vid behandling och diagnosticering av hiv-infektioner anvaendbara monoklonala antikroppar och peptider. Download PDF

Info

Publication number
FI873553A
FI873553A FI873553A FI873553A FI873553A FI 873553 A FI873553 A FI 873553A FI 873553 A FI873553 A FI 873553A FI 873553 A FI873553 A FI 873553A FI 873553 A FI873553 A FI 873553A
Authority
FI
Finland
Prior art keywords
och
monoclonala
infektioner
diagnosticering
antikroppar
Prior art date
Application number
FI873553A
Other languages
English (en)
Other versions
FI873553A0 (fi
Inventor
Mary K Shriver
Larry H Gosting
Janela Mcclure
Elaine K Thomas
Wesley L Cosand
George J Todaro
Robert C Nowinski
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of FI873553A0 publication Critical patent/FI873553A0/fi
Publication of FI873553A publication Critical patent/FI873553A/fi

Links

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI873553A 1986-08-20 1987-08-17 Vid behandling och diagnosticering av hiv-infektioner anvaendbara monoklonala antikroppar och peptider. FI873553A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (2)

Publication Number Publication Date
FI873553A0 FI873553A0 (fi) 1987-08-17
FI873553A true FI873553A (fi) 1988-02-21

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873553A FI873553A (fi) 1986-08-20 1987-08-17 Vid behandling och diagnosticering av hiv-infektioner anvaendbara monoklonala antikroppar och peptider.

Country Status (28)

Country Link
JP (1) JPS6485928A (fi)
KR (1) KR920008744B1 (fi)
AT (1) AT398080B (fi)
AU (1) AU616156B2 (fi)
BE (1) BE1000811A4 (fi)
CH (1) CH675728A5 (fi)
CS (1) CS275838B6 (fi)
DE (1) DE3727703A1 (fi)
DK (1) DK433087A (fi)
ES (1) ES2010727A6 (fi)
FI (1) FI873553A (fi)
FR (1) FR2603107B1 (fi)
GB (1) GB2196634B (fi)
GR (1) GR871298B (fi)
HU (1) HU214439B (fi)
IE (1) IE60671B1 (fi)
IL (1) IL83580A (fi)
IT (1) IT1222518B (fi)
LU (1) LU86972A1 (fi)
NL (1) NL8701950A (fi)
NO (2) NO300462B1 (fi)
NZ (1) NZ221440A (fi)
OA (1) OA08652A (fi)
PL (1) PL155084B1 (fi)
PT (1) PT85567B (fi)
SE (1) SE506025C2 (fi)
YU (1) YU152587A (fi)
ZW (1) ZW15487A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
JP2520464B2 (ja) * 1987-05-29 1996-07-31 タノツクス・バイオシステムズ・インコーポレーテツド Ｈｉｖ―１を中和するモノクロ―ナル抗体
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
AU621097B2 (en) * 1988-01-26 1992-03-05 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (fr) * 1988-06-06 1992-04-10 Pasteur Institut Peptides ayant des proprietes protectrices d'un virus pathogene du type hiv dans des cellules sensibles
KR900701836A (ko) * 1988-10-03 1990-12-04 라메쉬 엘. 라탄 신규 hiv 단백질 및 aids의 진단, 예방 또는 치료에 유용한 펩티드
CA2025481A1 (en) * 1989-09-19 1991-03-20 Peter J. Kniskern Vaccine for aids and hepatitis b
SE9000333D0 (sv) * 1990-01-31 1990-01-31 Britta Wahren Monoklonal antikropp
SE468168B (sv) * 1990-02-20 1992-11-16 Replico Medical Ab Hiv-1, p24 peptider, diagnostiska antigener och foerfarande foer saerskiljande diagnostik av preliminaert hiv-1 positiva serumprov
JPH03271233A (ja) * 1990-03-19 1991-12-03 Inst Pasteur ウイルスエンベロープ糖タンパク質及びその糖タンパク質の中和エピトープに対応するペプチドの間の相乗作用による、ウイルス性感染に対する防御の誘発
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (ja) * 1991-09-30 1993-11-22 Nitto Denko Corp Ｈｉｖ関連環状ペプチドおよびこれを固定化した吸着体
DE69329023T2 (de) * 1992-03-27 2001-03-22 Advanced Immunitt Inc T-peptid und damit verwandte peptide in der behandlung von entzündungen einschliesslich der multiplen sklerose
NZ597677A (en) 2005-12-09 2013-05-31 Vectus Biosystems Ltd Vip fragments and methods of use
WO2010026940A1 (ja) 2008-09-02 2010-03-11 日本特殊陶業株式会社 スパークプラグ

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
ATE86636T1 (de) * 1984-10-18 1993-03-15 Pasteur Institut F antigene vom menschlichen immunodefizienz-virus und deren verwendungen.
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
WO1986006099A1 (en) * 1985-04-08 1986-10-23 Genetic Systems Corporation EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
JPS63501716A (ja) * 1985-10-24 1988-07-14 サウスウエスト・ファウンデ−ション・フォア・バイオメディカル・リサ−チ 合成ペプチドおよびａｉｄｓおよびａｒｃの診断ならびにワクチン注射へのその使用
EP0245459B1 (en) * 1985-11-07 1993-09-29 The President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
DK169582B1 (da) * 1986-06-23 1994-12-12 Squibb Bristol Myers Co Humant monoklonalt antistof, der er i stand til at reagere med en epitop på LAV/HTLV-III kappeglycoproteinet gp41, cellelinier, som producerer sådant antistof, farmaceutisk præparat indeholdende antistoffet samt fremgangsmåde til bestemmelse af nærværelsen af LAV/HTLV-III i en biologisk prøve og fremgangsmåde til separering af specifikke antigendeterminanter af LAV/HTLV-III under anvendelse af ant
EP0525828A3 (en) * 1986-08-01 1993-02-24 Repligen Corporation Recombinant polypeptides and their uses, including assay for aids virus
AU592258B2 (en) * 1986-12-30 1990-01-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

Also Published As

Publication number Publication date
IL83580A (en) 1992-11-15
BE1000811A4 (fr) 1989-04-11
DK433087D0 (da) 1987-08-19
CS8706136A2 (en) 1990-08-14
FR2603107B1 (fr) 1992-04-24
JPS6485928A (en) 1989-03-30
DK433087A (da) 1988-02-21
NO302176B1 (no) 1998-02-02
AU7720187A (en) 1988-05-19
IT1222518B (it) 1990-09-05
ATA208987A (de) 1994-01-15
NO873495D0 (no) 1987-08-19
NZ221440A (en) 1991-11-26
PL155084B1 (en) 1991-10-31
NO300462B1 (no) 1997-06-02
GB8719587D0 (en) 1987-09-23
YU152587A (sh) 1992-09-07
PT85567B (pt) 1991-02-08
IE872219L (en) 1988-02-20
GR871298B (en) 1988-01-12
AT398080B (de) 1994-09-26
FR2603107A1 (fr) 1988-02-26
ES2010727A6 (es) 1989-12-01
SE506025C2 (sv) 1997-11-03
SE8703225D0 (sv) 1987-08-19
AU616156B2 (en) 1991-10-24
SE8703225L (sv) 1988-02-21
KR890002547A (ko) 1989-04-10
IT8721678A0 (it) 1987-08-19
ZW15487A1 (en) 1988-09-14
CH675728A5 (fi) 1990-10-31
NO934897L (no) 1993-12-29
PL267401A1 (en) 1988-07-21
IE60671B1 (en) 1994-08-10
NO934897D0 (no) 1993-12-29
HUT44619A (en) 1988-03-28
HU214439B (hu) 1998-03-30
NL8701950A (nl) 1988-03-16
OA08652A (fr) 1988-11-30
PT85567A (en) 1987-09-01
CS275838B6 (en) 1992-03-18
LU86972A1 (fr) 1988-03-02
GB2196634B (en) 1991-05-15
GB2196634A (en) 1988-05-05
FI873553A0 (fi) 1987-08-17
IL83580A0 (en) 1988-01-31
NO873495L (no) 1988-02-22
KR920008744B1 (ko) 1992-10-09
DE3727703A1 (de) 1988-05-05

Similar Documents

Publication Publication Date Title
FI873840A0 (fi) Polyestrar innehaollande alkylenoxidsegment och anvaendning av dessa vid administrering av laekemedel.
FI873553A (fi) Vid behandling och diagnosticering av hiv-infektioner anvaendbara monoklonala antikroppar och peptider.
FI875038A (fi) Foerfarande och anordning vid vakuumfoerpackning.
FI873805A0 (fi) Foerfarande foer framstaellning av reproduktionsskikt och deras anvaendning vid framstaellning av flexotryckplaotar.
FI871753A0 (fi) Foerfarande och anordning vid sjaelvgaoende handmanoevrerad vibratorplatta.
FI861937A0 (fi) Foerfarande och anordning foer foerminskning av dammanhopningar vid gasbehandling i smaeltugn.
FI862150A0 (fi) Foerfarande och anordning foer styrning av effekt vid en likspaenningskaella.
FI861665A (fi) Foerfarande och arrangemang foer foerverkling bromstrycksreglering och luftfjaedringsreglering och oeverbelastningsskydd vid nyttofordon.
FI863458A (fi) Foerfarande foer boejningskompensering av laeppbalken i en pappersmaskin och anlaeggning foer anvaendning vid foerfarandet.
FI860321A0 (fi) Foerfarande och anordning foer upptagning och aotergivning av bildinformation vid roentgenpanoramaavbildning.
FI863533A (fi) Foerfarande och anordning vid uppsamling av livsmedelsvaetskor.
FI884628A0 (fi) Saett vid instyrning av en okantad braeda till en kantningsutrustning och anordning foer genomfoerande av saettet.
FI872799A0 (fi) Anordning foer fyllande av en skivpress med spaonplattor vid framstaellning av fiberplattor och liknande.
FI865173A (fi) En koppling med en vid ingaongen enpoligt kopplad fyrpol och en foerstaerkare foer kompensation av restpotential.
FI862516A0 (fi) Foerfarande och anordning vid torkning av paelsdjursskinn.
FI864932A0 (fi) Foerfarande och arrangemang vid pendeltransportoer foer tillverkning av mineralullsbana.
FI864661A0 (fi) Foerfarande och anordning foer utfoerande av kantupphaengning vid en ihaolig platta.
FI860899A0 (fi) Kaelke och foerfarande vid motorisering av kaelken.
FI861965A0 (fi) Foerfarande vid virkessorteringsanlaeggningar och anordning vid sortering av virke.
FI861636A0 (fi) Anordning foer uppraetthaollande av renlighet vid vaogar och maerkningsanordningar.
FI864386A0 (fi) Foerfarande och anordning foer uppvaermning av vid vintermurning anvaenda murstenar.
FI861891A0 (fi) Foerfarande och anordning foer minskning av bullerolaegenheterna vid en med chopperprincip matad elmotor.
FI864048A0 (fi) Foerfarande och anordningar vid banformningspartiet i en pappersmaskin.
FI873687A0 (fi) Kombination av expertsystemteknik och moensterigenkaenningsteknik vid utnyttjande av datorlaest textmassa.
FI872873A0 (fi) Foerfarande och anordning foer maetning av hopplaengd vid backhoppning.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: GENETIC SYSTEMS CORPORATION